Key facts
- This page summarizes Steven Robert Wedan's Form 3 filing for Imricor Medical Systems, Inc..
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 18 May 2026, 17:41.
Steven Robert Wedan - 18 May 2026 Form 3 Insider Report for Imricor Medical Systems, Inc.
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 18 May 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Steven Robert Wedan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Steven Robert Wedan filed Form 3 for Imricor Medical Systems, Inc. on 18 May 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002132261
Primary reporting owner
Wedan Steven Robert
- Relationship
- President and CEO, Director
- Address
- C/O IMRICOR MEDICAL SYSTEMS, INC., 400 GATEWAY BLVD, BURNSVILLE
- Signature
- /s/ Steven Robert Wedan
- Signature date
- 18 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
No ticker
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,083,586
- Date
- 18 May 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 1,060,800
- Exercise price
- $0.5200
- Footnotes
- F3
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 200,000
- Exercise price
- $0.9800
- Footnotes
- F4
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 301,997
- Exercise price
- $0.8900
- Footnotes
- F5
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 445,337
- Exercise price
- $0.3000
- Footnotes
- F6
No ticker
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 May 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 113,973
- Exercise price
- $1.07
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
The amount of securities beneficially owned in column 2 includes 3,077,573 shares of the issuer's Class A Common Stock underlying the same number of CHESS Depositary Interests ("CDIs"). The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty Limited, a subsidiary of ASX Limited, the company that operates the ASX.
Footnote F2
The amount of securities beneficially owned in column 2 includes (i) 1,427,373 shares held jointly with Cherri Wedan, (ii) 20,000 shares held by PENSCO Trust Company LLC Cust FBO Steve Wedan IRA, and (iii) 458,640 shares held by PENSCO Trust Company LLC Cust FBO Steve Wedan Roth IRA.
Footnote F3
This option was granted on March 15, 2019, and vested in multiple installments over approximately three years from the grant date. This option is 100% vested.
Footnote F4
This option was granted on August 30, 2019, and vested in multiple installments over approximately four years from the grant date. This option is 100% vested.
Footnote F5
Represents the vested portion of the option granted on May 13, 2020. This option vested in multiple time-based installments and upon the achievement of certain performance milestones. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.
Footnote F6
Represents the vested portion of the option granted on May 15, 2024. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.
Footnote F7
Represents the vested portion of the option granted on May 14, 2025. This portion vested upon the achievement of a certain performance milestone. A portion of this option is not reported here because it remains subject to performance-based vesting conditions that have not yet been achieved.